Townsend Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
4,405
-188
-4% -$64.4K 0.51% 51
2026
Q1
$1.62M Buy
4,593
+63
+1% +$22.5K 0.58% 39
2025
Q4
$1.48M Sell
4,530
-15
-0.3% -$4.76K 0.52% 46
2025
Q3
$1.28M Sell
4,545
-58
-1% -$16.8K 0.46% 49
2025
Q2
$1.29M Sell
4,603
-233
-5% -$66K 0.47% 49
2025
Q1
$1.51M Buy
4,836
+451
+10% +$133K 0.58% 43
2024
Q4
$1.14M Buy
4,385
+2,166
+98% +$643K 0.42% 52
2024
Q3
$715K Buy
2,219
+709
+47% +$232K 0.27% 71
2024
Q2
$472K Buy
1,510
+80
+6% +$23.5K 0.18% 88
2024
Q1
$407K Hold
1,430
0.16% 93
2023
Q4
$412K Hold
1,430
0.19% 84
2023
Q3
$384K Buy
1,430
+22
+2% +$5.49K 0.19% 87
2023
Q2
$313K Sell
1,408
-373
-21% -$86.5K 0.15% 98
2023
Q1
$431K Buy
1,781
+15
+0.8% +$3.68K 0.22% 83
2022
Q4
$464K Buy
1,766
+495
+39% +$133K 0.23% 84
2022
Q3
$286K Hold
1,271
0.16% 102
2022
Q2
$309K Hold
1,271
0.16% 107
2022
Q1
$307K Buy
1,271
+55
+5% +$12.6K 0.15% 106
2021
Q4
$274K Sell
1,216
-85
-7% -$17.9K 0.13% 118
2021
Q3
$277K Sell
1,301
-72
-5% -$16.6K 0.15% 118
2021
Q2
$335K Buy
1,373
+434
+46% +$107K 0.19% 100
2021
Q1
$234K Sell
939
-300
-24% -$71.6K 0.14% 124
2020
Q4
$285K Sell
1,239
-704
-36% -$162K 0.19% 106
2020
Q3
$494K Sell
1,943
-22
-1% -$5.45K 0.4% 65
2020
Q2
$463K Buy
1,965
+8
+0.4% +$1.82K 0.37% 71
2020
Q1
$397K Buy
1,957
+6
+0.3% +$1.31K 0.41% 65
2019
Q4
$470K Buy
+1,951
New +$430K 0.38% 72

Other funds holding AMGN

Townsend Asset Management's AMGN Position: Q2 2026 in Review

Townsend Asset Management reduced its Amgen (AMGN) stake by 4.1% in Q2 2026, selling an estimated $64.4K and leaving 4,405 shares worth $1.6M. The position accounts for 0.51% of the portfolio, ranked #51.

Townsend Asset Management first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.62M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Townsend Asset Management held 4,405 shares of Amgen worth $1.6M as of Q2 2026.
  • Townsend Asset Management sold 188 Amgen shares in Q2 2026, an estimated $64.4K.
  • Amgen made up 0.51% of Townsend Asset Management's portfolio in Q2 2026, its #51 holding.
  • Townsend Asset Management first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Townsend Asset Management's Amgen position peaked at $1.62M in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Townsend Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.